Peer-reviewed journal articles published within the last six months are listed here, linked from relevant news stories when appropriate. To learn more on how to best read and interpret the findings from clinical research, see In Brief: Interpreting Research Studies from the Guttmacher Institute.
Prevention
Arasteh K, Des Jarlais DC. Injecting drug use, HIV, and what to do about it. The Lancet. 2008 Nov 15. 372(9651):1709-1710.
Balaji A et al. Trends in HIV- and STD-related risk behaviors among high school students. Morbidity and Mortality Weekly Report 2008;57(30):817-822 and 822-825.
Bongaarts, J, Buettner T, Heilig G, Pelletier F. Has the HIV epidemic peaked? Population and Development Review 34(2): 199–224 (June 2008).
Bristol N. New hopes for tackling HIV/AIDS in the USA. The Lancet. 2008 Nov; 372(9653):1869-1870.
Cadogan M, Dalgleish AG. HIV immunopathogenesis and strategies for intervention. The Lancet Infectious Diseases 2008; 8:675-684.
Coates TJ, Richter L, Caceres C. Behavioural strategies to reduce HIV transmission: how to make them work better.The Lancet Series, HIV Prevention, early online publication. 2008.
Cook JA et al. Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women. AIDS 22:1355-1363. 2008.
Cutler B, Justman J. Vaginal microbicides and the prevention of HIV transmission. The Lancet Infectious Diseases 2008; 8:685-697.
Darbes L, Crepaz N, Lyles C, Kennedy G, Rutherford G. The efficacy of behavioral interventions in reducing HIV risk behaviors and incident sexually transmitted disease in heterosexual African Americans. AIDS. 2008 Jun 19.
DiNoia J, Schinke SP. HIV risk-related attitudes, interpersonal influences, and intentions among at-risk urban, early adolescent girls. Am J Health Behav. 2008 Sep-Oct; 32(5):497-507.
Granich RM, Gilks CF, Dye C, et al. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. The Lancet, Early Online Publication, 2008 Nov 26.
Horvath KJ, Rosser BR, Remafedi G. Sexual risk taking among young internet-using men who have sex with men. Am J Public Health. 2008 Apr 29.
Kissinger P, Liddon N, Schmidt N et al. HIV/STI risk behaviors among Latino migrant workers in New Orleans post-hurricane Katrina disaster. Sexually Transmitted Diseases. 35(11):924-929, November 2008
Masaro CL, Dahinten VS, Johnson J, Ogilvie G, Patrick DM. Perceptions of sexual partner safety. Sex Transm Dis. 2008 Jun;35(6):566-71.
Mathers BM, Degenhardt L, Phillips B et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. The Lancet. 2008 Nov 15. 372(9651):1733-1745.
Merson M, Padian N, Coates TJ, et al. Combination HIV prevention. The Lancet. 2008 Nov; 372(9652): 1805-1806.
Middelkoop K, et al. Adolescent and adult participation in an HIV vaccine trial preparedness cohort in South Africa. Journal of Adolescent Health 43(2008);8-14.
Padian NS, Buve A, Balkus J, Serwadda D, Cates W. Biomedical interventions to prevent HIV infection: evidence, challenges, and way forward. The Lancet 2008; 273:585-599.
Townsend CL, Cortina-Borja MA, Peckham CS, et al. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS; 2008 May 11; 22(8):973-81.
van de Wijgert JH, Morrisoon CS, Cornelisse PG, et al. Bacterial vaginosis and vaginal yeast, but not vaginal cleansing, increase HIV-1 acquisition in African women. J Acquir Immune Defic Syndr. 2008 Jun 1; 48(2):203-10.
Veazey RS, Ketas TA, Klasse PJ, Davison DK, Singletary M, Green LC, Greenberg ML, Moore JP. Tropism-independent protection of macaques against vaginal transmission of three SHIVs by the HIV-1 fusion inhibitor T-1249. Proc Natl Acad Sci USA 2008 Jul 22.
Wilson DP, Coplan PM, Wainberg MA, Blower SM. The paradoxical effects of using antiretroviral-based microbicides to control HIV epidemics. Proc Natl Acad Sci USA. 2008 Jul 7.
Wong FL, Rotheram-Borus, MJ, Lightfoot M, Pequegnat W, Comulada WS, Cumberland W, Weinhardt LS, Remien RH, Chesney M, Johnson M. Healthy Living Trial Group. Effects of behavioral intervention on substance use among people living with HIV: the Healthy Living Project randomized controlled study. Addiction 2008;103(7):1206-1214.
Care
Bernstein KT, Liu KL, Begier EM, Koblin B, Karpati A, Murril C. Same-sex attraction disclosure to health care providers among New York City men who have sex with men – Implications for HIV testing approaches. Archives of Internal Medicine July 14 2008; 168(4): 1458-1464.
Bhaskaran K, Hamouda O, Sannes M, Boufassa F, Johnson AM, Lambert PC, Porter K, CASCAD Collaboration. Changes in the Risk of Death After HIV Seroconversion Compared With Mortality in the General Population. JAMA. 2008;300(1):51-59.
Bouhnik AD et al. Sexual difficulties in people living with HIV in France—results from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA). AIDS and Behavior 12: 670-676, 2008.
D’Souza G, Wiley D, Li X, CHimiel J, Margolick JB, Cranston RD, Jacobson LP. Incidence and epidemiology of anal cancer in the Multicenter AIDS Cohort Study. JAIDS. 48(4):491-499, August 1 2008.
Havlir DV, Getahun H, Sanne I, Nunn P. Opportunities and challenges for HIV care in overlapping HIV and TB epidemics. JAMA. 2008;300(4):423-430.
Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, Wodak A, Panda S, Tyndall M, Toufik A, Mattick RP; for the 2007 Reference Group to the UN on HIV and Injecting Drug Use. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008 Sep 23.
Paediatric and Perinatal HIV/AIDS in Jamaica. West Indian Medical Journal. Special Issue 2008, June. 57(3):187-320.
Triant VA, Brown TT, Lee H, Grinspoon SK. Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large US healthcare system. J Clin Endocrincol Metab. 2008 Sep; 93(9):3499-504. Epub 200 Jul 1.
Wilson DP, Law MG, Grulich AE, Cooper DA, Kaldor JM. Relation between HIV viral load and infectiousness: a model-based analysis. The Lancet 2008; 372:314-320.
Yacisin K, Maida I, Rios MJ, Soriano V, Nunez M. Hepatitis C virus coinfection does not affect CD4 restoration in HIV-infected patients after initiation of antiretroviral therapty. AIDS Res Hum Retroviruses. 2008 Jul 1.
Treatment
Anema A, Wood E, Montaner J. The use of highly active retroviral therapy to reduce HIV incidence at the population level. Canadian Medical Association Journal. 2008 July 1;179(1):13-14.
Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. The Lancet 2008; 372:293-299.
Autran B et al. Greater viral rebound and reduced time to resume antiretroviral therapy after therapeutic vaccination with ALVAC-HIV vaccine (vCP1452). AIDS 22(11):1313-1322. 2008.
Bailey JR et al. Transmission of Human Immunodeficiency Virus Type 1 from a patient who developed AIDS to an Elite Suppressor. Journal of Virology. 008;82(15):7395-7410.
Carrat F et al. Serum alpha-fetoprotein predicts virologic response to Hepatitis C treatment in HIV coinfected patients. AIDS. 22(12):1513-1515, July 31, 2008.
Celum C et al. Effect of acyclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: A randomized, double-blind, placebo-controlled trial. Lancet. 2008 June; 371(9630):2109-2119.
The Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study group. Response to combination antiretroviral therapy: variation by age. AIDS. 22(12):1463-1473, July 31, 2008.
Foster SB, et al. Increased incidence of asthma in HIV-infected children treated with highly active antiretroviral therapy in the National Institutes of Health Women and Infants Transmission Study. Journal of Allergy and Clinical Immunology.
Ghanem KG, Moore RD, Rompalo AM, Erbelding EJ, Zenilman JM, Gebo KA. Antiretroviral therapy is associated with reduced serologic failure rates for syphilis among HIV-infected patients.Clin Infect Dis. 2008 Jul 15;47(2):258-65.
Havlir DV, Getahun H, Sanne I, Nunn P. Opportunities and Challenges for HIV Care in Overlapping HIV and TB Epidemics JAMA.2008;300(4):423-430.
He W, Neil S, Kulkarni H, Wright E, Agan BK, Marconi VC, Dolan MJ, Weiss RA, Ahuja SK. Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility. Cell Host and Microbe. 2008 17 July; 4: 52-62.
Kumwenda NI et al. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med. 2008 Jul 10;359(2):119-29.
Lester R, Karanja S. Mobile phones: exceptional tools for HIV/AIDS, health, and crisis management. The Lancet Infectious Diseases. 2008 Dec; 8(12): 738-739.
Lima VD, Johnston K, Hogg RS, Levy AR, Harrigan PR, Anema A, Montaner JSG. Expanded access to highly active antiretroviral therapy: A potentially powerful strategy to curb the growth of the HIV epidemic. J Infect Dis. 2008 Jul 1;198(1):59-67.
Powers KA, Poole C, Pettifor AE, Cohen MS. Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis. The Lancet Infectious Diseases 2008; 8:553-563.
Sherr L, et al. Suicidal ideation in UK HIV clinic attenders. AIDS August 20 2008. 22(13):1651-1658.
Silverman JG, Decker MR, Saggurti N, Balaiah D, Raj A. Intimate partner violence and HIV infection among married Indian women. JAMA. 2008;300(6):703-710.
Vernazza P, Hirschel B, Bernasconi E, Flepp M. HIV transmission under highly active antiretroviral therapy. The Lancet. 2008 Nov; 372(9652):1806-1807.
Wilson DP, Law MG, Gruilich AE, et al. HIV transmission under highly active antiretroviral therapy- author’s reply. The Lancet. 2008 Nov; 372(9652):1807.
Journal of AIDS/HIV
Advocacy
Frost, JJ. Trends in US women’s use of sexual and reproductive health care services, 1995-2002. Am J Public Health. 2008 Aug 13.
Khan S, Mishra V, Macro International Inc., DHS Comparative Reports No. 19 - Youth and Reproductive and Sexual Health. USAID. August 2008.
Morris K. Loss of patients from HIV programmes a global issue. The Lancet Infectious Diseases. 2008 Dec; 8(12): 742-743.
Peters VB, Liu KL, Robinson LG, Dominguez KL, Abrams EJ, Gill BS, Thomas PA. Trends in perinatal HIV prevention in New York City, 1994-2003. AJPH. 2007.110023.
Prejean J, Song R, An Q, Hall HI. Subpopulation estimates from the HIV incidence surveillance system—United States, 2006. MMWR Weekly. 2008 Sept 12; 57(36):985-989.
Rectal Microbicides: Investments and Advocacy from the International Rectal Microbicide Working Group
